Zai Lab, a biopharmaceutical company, has disclosed its commitment to achieving net-zero emissions by 2025. The company’s latest filings mentioned the keywords 'Emissions/ Emission' most number of times in relation to ‘Net-Zero’.

Zai Lab has disclosed its current carbon emissions and greenhouse gas (GHG) emissions for scope 1, scope 2, and scope 3. The company's total emissions for 2022 were 73,482 tCO2e, with scope 1 emissions at 19 tCO2e, scope 2 emissions at 3,951 tCO2e. The breakdown of company’s Scope 3 emissions is as follows - Waste generated in operations: 43 tCO2e, Fuel- and Energy related activities: 1,109 tCO2e, Upstream transportation and distribution: 1,988 tCO2e, Business travel: 6,542 tCO2e, Capital goods: 8,786 tCO2e, and Purchased goods and services: 51,051 tCO2e.

To achieve its net-zero targets, Zai Lab has taken steps to reduce emissions, including implementing a Global EHS management system to monitor and continually improve EHS performance. The company has also disclosed its commitments and actions related to climate change and environmental stewardship in its Climate Change and Environmental Stewardship Position Statement. In 2023, the company conducted a comprehensive greenhouse gas (GHG) inventory, encompassing Scope 1, Scope 2, and Upstream Scope 3 emissions. This inventory included a thorough assessment of its entire value chain to pinpoint areas with significant emissions, both upstream and downstream from its operations with the 2022 as the baseline. The primary goal of this effort was to gain insights into the present operational footprint, analyze environmental and climate risks associated with its activities, and identify opportunities for improvement and mitigation.

In conclusion, Zai Lab has disclosed its commitment to achieving net-zero emissions and has set targets reducing emissions by 2025. The company has taken steps to reduce emissions and has conducted assessments of its value chain to identify emission areas and mitigate them.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Company Filings Analytics uses machine learning to uncover key insights and track sentiment across millions of regulatory filings and other corporate disclosures for thousands of companies representing the world’s largest industries. This analysis is combined with crucial details on strategic and investment priorities, innovation strategies, and CXO insights to provide comprehensive company profiles.